19.8 C
New York
Friday, July 4, 2025

Tag: 14

"Empower Your Wealth: Discover the Top 2 Stocks I’m Loving for Smart Investing!"

Hey fabulous money mavens! Today, we’re diving into some juicy investment insights inspired by none other than Bill Ackman, a hedge fund superstar who's...

Shanghai summer kicks off with ‘Easy Go’

SHANGHAI, July 4, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn ...

BIC: Half-Year Liquidity Contract Statement

Société BIC Half-Year Liquidity Contract Statement

Sinopec Launches China’s First Floating Offshore PV Project, Advancing Green Energy Innovation

QINGDAO, China, July 4, 2025 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec"), joining hands with Shandong Province and Qingdao Municipality, has successfully commenced...

SOILBUILD INTERNATIONAL BREAKS NEW GROUND IN VIETNAM WITH SPECTRUM HƯNG YÊN INDUSTRIAL LAUNCH IN 2025

HANOI, Vietnam, July 4, 2025 /PRNewswire/ -- Soilbuild International has officially broken ground on Spectrum Hung Yen, a cutting-edge industrial development spanning over 14.45 hectares in...

Cegedim Assurances et Shift Technology franchissent une nouvelle étape avec un 14ème client commun

Une collaboration qui confirme sa pertinence face aux nouveaux enjeux de la lutte contre la fraude et les paiements à tort dans l’assurance santé

Strüngmann Award zeichnet Gründerteam von Araris Biotech als Preisträger 2025 aus

München, Deutschland, 04. Juli 2025 – Das Komitee des Strüngmann Award gab heute bekannt, dass Dr. Dragan Grabulovski, Dr. Philipp Spycher und Dr. Isabella Attinger-Toller, die Gründer von Araris Biotech, als die diesjährigen Preisträger ausgezeichnet wurden. Der Award verfolgt das Ziel, herausragende unternehmerische und wissenschaftliche Leistungen sowie bahnbrechende Ideen in der Life-Science-Branche zu fördern. Das Gründerteam von Araris Biotech überzeugte nicht nur durch die Entwicklung einer neuartigen Technologie im Bereich der Antikörper-Wirkstoff-Konjugate, sondern auch durch deren erfolgreiche Validierung in Form von Partnerschaften und einem präklinischen Exit. Diese neue Medikamentenklasse hat das Potenzial, maßgeblich zur Weiterentwicklung zielgerichteter Krebstherapien beizutragen und somit einen Mehrwert für Menschen mit Krebserkrankungen weltweit zu erreichen. 

Transaction in Own Shares

Transaction in Own Shares

Snow Caps THCA Flower – Extra Frosty Exotic Cannabis Strains Now Available for Sale

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

Cascadia Announces Closing of Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 3, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia")...

BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS

-Record earnings increasing to $0.19 per share -Record operating income of $16.8 million, reflecting a 27% increase from prior year OLATHE, Kan., July 3, 2025 /PRNewswire/...

March of Dimes Statement on the Passage of H.R. 1

ARLINGTON, Va., July 3, 2025 /PRNewswire-HISPANIC PR WIRE/ -- The passage of H.R. 1, the "One Big Beautiful Bill Act," sets in motion harmful...

March of Dimes Statement on the Passage of H.R. 1

ARLINGTON, Va., July 3, 2025 /PRNewswire/ -- The passage of H.R. 1, the "One Big Beautiful Bill Act," sets in motion harmful changes to...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags14